Gastrisk aspirationsbehandling er et muligt alternativ til behandling af fedme

Aspiration therapy with AspireAssist is a novel endoscopic
obesity treatment. Patients aspirate approximately 30% of
an ingested meal through a draining system connected to a
percutanous endoscopic gastrostomy tube. AspireAssist
was recently approved by the US Food and Drug Administration,
and it induces weight loss comparable to the
weight loss observed after bariatric surgery, but with a
lower risk of complications. Few clinical studies about the
efficacy and safety of AspireAssist have been carried out
and published. Thus, further intervention studies evaluating
acute as well as long-term effects are warranted.